Sera Prognostics, Inc. (SERA)
USD 8.18
(-0.37%)
USD 8.18
(-0.37%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -36.24 Million USD | 18.09% |
| 2022 | -44.24 Million USD | -22.13% |
| 2021 | -36.22 Million USD | -67.67% |
| 2020 | -21.6 Million USD | -5.71% |
| 2019 | -20.43 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -8.09 Million USD | -2.17% |
| 2024 Q2 | -8.3 Million USD | -2.54% |
| 2023 Q1 | -9.81 Million USD | -0.32% |
| 2023 FY | -36.24 Million USD | 18.09% |
| 2023 Q3 | -7.21 Million USD | 31.61% |
| 2023 Q2 | -10.54 Million USD | -7.39% |
| 2023 Q4 | -7.92 Million USD | -9.92% |
| 2022 Q2 | -11.29 Million USD | 6.78% |
| 2022 Q1 | -12.11 Million USD | 2.95% |
| 2022 Q4 | -9.78 Million USD | 3.85% |
| 2022 FY | -44.24 Million USD | -22.13% |
| 2022 Q3 | -10.17 Million USD | 9.88% |
| 2021 Q2 | -6.3 Million USD | 0.82% |
| 2021 FY | -36.22 Million USD | -67.67% |
| 2021 Q4 | -12.48 Million USD | -26.63% |
| 2021 Q1 | -6.35 Million USD | -18.31% |
| 2021 Q3 | -9.85 Million USD | -56.32% |
| 2020 Q2 | -4.7 Million USD | -0.19% |
| 2020 Q1 | -4.69 Million USD | 0.0% |
| 2020 Q4 | -5.37 Million USD | -5.97% |
| 2020 FY | -21.6 Million USD | -5.71% |
| 2020 Q3 | -5.07 Million USD | -7.8% |
| 2019 FY | -20.43 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 84.412% |
| Prenetics Global Limited | -62.72 Million USD | 42.22% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -2241.214% |
| CareDx, Inc | -190.28 Million USD | 80.954% |
| Exact Sciences Corporation | -204.14 Million USD | 82.247% |
| Exagen Inc. | -23.68 Million USD | -52.991% |
| Inotiv, Inc. | -105.14 Million USD | 65.53% |
| Guardant Health, Inc. | -479.44 Million USD | 92.441% |
| Biodesix, Inc. | -52.14 Million USD | 30.499% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -1278.524% |
| Precipio, Inc. | -5.85 Million USD | -519.204% |
| iSpecimen Inc. | -11.09 Million USD | -226.52% |
| Natera, Inc. | -434.8 Million USD | 91.665% |
| Aspira Women's Health Inc. | -16.69 Million USD | -117.148% |
| Standard BioTools Inc. | -74.65 Million USD | 51.455% |
| 23andMe Holding Co. | -666.7 Million USD | 94.564% |
| Castle Biosciences, Inc. | -57.46 Million USD | 36.933% |
| Personalis, Inc. | -108.29 Million USD | 66.534% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 59.04% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -264.349% |
| OpGen, Inc. | -32.66 Million USD | -10.939% |
| T2 Biosystems, Inc. | -50.07 Million USD | 27.627% |
| Myriad Genetics, Inc. | -112 Million USD | 67.641% |
| ICON Public Limited Company | 612.33 Million USD | 105.919% |
| NeoGenomics, Inc. | -87.96 Million USD | 58.801% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -2241.214% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 104.289% |
| RadNet, Inc. | 3.04 Million USD | 1290.604% |
| MDxHealth SA | -43.1 Million USD | 15.912% |
| Psychemedics Corporation | -4.15 Million USD | -772.46% |
| Illumina, Inc. | -1.16 Billion USD | 96.878% |
| Check-Cap Ltd. | -17.56 Million USD | -106.296% |
| Twist Bioscience Corporation | -208.72 Million USD | 82.637% |
| DarioHealth Corp. | -59.42 Million USD | 39.014% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 78.405% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -260.249% |
| OPKO Health, Inc. | -188.86 Million USD | 80.81% |
| Medpace Holdings, Inc. | 282.81 Million USD | 112.815% |
| Neogen Corporation | -9.42 Million USD | -284.694% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -256.826% |
| Prenetics Global Limited | -62.72 Million USD | 42.22% |
| Mainz Biomed B.V. | -26.29 Million USD | -37.825% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -356.62% |
| Trinity Biotech plc | -24.01 Million USD | -50.895% |
| Neuronetics, Inc. | -30.18 Million USD | -20.05% |
| Sotera Health Company | 51.37 Million USD | 170.543% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -356.62% |